Having trouble accessing articles? Reset your cache.

Techniques: Crystal structure of myeloid leukemia cell differentiation protein (MCL1)

Drug platforms

TECHNOLOGY: Crystal structures

Crystallographic studies on an MCL1 fusion protein could aid the structure-based design of MCL1-specific inhibitors. A fusion of maltose binding protein

Read the full 244 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE